Children with special health care needs (CSHCN) often face significant disruptions in their education due to extended hospitalizations. A recent study published online in Disability and Rehabilitation on July 1, 2024, by a multidisciplinary team of Kessler Foundation and Children Specialized Hospital.
ViiV’s long-acting Cabenuva beats out daily oral HIV treatments in PhIII
ViiV Healthcare had already shown that its long-acting injectable Cabenuva was just as effective as daily oral treatments as well as preferred by patients for